Expression of the Pokemon Proto-oncogene in Nasopharyngeal Carcinoma Cell Lines and Tissues

  • Jiao, Wei (Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Liu, Fei (Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Tang, Feng-Zhu (Department of Otorhinolaryngology, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Lan, Jiao (Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Xiao, Rui-Ping (Research Center of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Chen, Xing-Zhou (Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Ye, Hui-Lan (Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region) ;
  • Cai, Yong-Lin (Key Laboratory of Nasopharyngeal Carcinama Etiology and Molecular Mechanism, Wuzhou Red Cross Hospital)
  • Published : 2013.11.30


To study the differentiated expression of the proto-oncogene Pokemon in nasopharyngeal carcinoma (NPC) cell lines and tissues, mRNA and protein expression levels of CNE1, CNE2, CNE3 and C666-1 were detected separately by reverse transcription polymerase chain reaction (RT-PCR), real-time PCR and Western-blotting. The immortalized nasopharyngeal epithelial cell line NP69 was used as a control. The Pokemon protein expression level in biopsy specimens from chronic rhinitis patients and undifferentiated non keratinizing NPC patients was determined by Western-blotting and arranged from high to low: C666-1>CNE1>CNE2> CNE3>NP69. The Pokemon mRNA expression level was also arranged from high to low: CNE1>CNE2>NP69>C666-1>CNE3. Pokemon expression of NP69 and C666-1 obviously varied from mRNA to protein. The Pokemon protein level of NPC biopsy specimens was obviously higher than in chronic rhinitis. The data suggest that high Pokemon protein expression is closely associated with undifferentiated non-keratinizing NPC and may provide useful information for NPC molecular target therapy.


Nasopharyngeal carcinoma (NPC);proto-oncogene;Pokemon;expression;cell lines;tissues


  1. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D (1995). The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin- binding proteins. Cell Growth Differ, 6, 1193-8.
  2. Andersson-Anvret M, Forsby N, Klein G, Henle W, Biorklund A (1979). Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients. Int J Cancer, 23, 762-7.
  3. Barnes I, Eveson JW, Reichart P, Sidransky D (2005). World Health Organization classification of tumours: Pathology and genetics head and neck tumours. International Agency for Research on Cancer, Lyon pp 81-105.
  4. Cheung ST, Huang DP, Hui AB, et al (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Esptein-Barr virus. Int J Cancer, 83, 121-6.<121::AID-IJC21>3.0.CO;2-F
  5. Choi WI, Jeon BN, Yun CO, et al (2009). Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem, 284, 12633-44.
  6. Collins T, Stone JR, Williams AJ (2001). All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol Cell Biol, 21, 3609-15.
  7. Davies JM, Hawe N, Kabarowski J, et al (1999). Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene, 18, 365-75.
  8. Department of Virology, Cancer Institute, Chinese Academy of Medical Sciences (1978). The stablishment of human nasopharyngeal carcinoma epithelial cell line and spindle cell line. Sci China, 1, 113-8.
  9. Gao W, Sui J, Li X, Ma J, Ren YX (2009). The expression and significance of oncogene pokemon in nasopharyngeal carcinoma. Mod Oncol, 17, 37-41.
  10. Gu SY, Tang WP, Zeng Y, et al (1983). An Epithelial cell line established from poorly differentiated nasopharyngeal carcinoma. Ai Zheng, 2, 70-2.
  11. Han BL, Xu XY, Zhang CZ, et al (2012). Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev, 13, 2577-81.
  12. Huang TR, Zhang SW, Chen WQ, et al (2012). Trends in nasopharyngeal carcinoma mortality in China, 1973-2005. Asian Pac J Cancer Prev, 13, 2495-502.
  13. Jin XL, Sun QS, Liu F, et al (2013). MicroRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. J Cell Biochem, 114, 1625-33.
  14. Kelly KF, Daniel JM (2006). POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol, 16, 578-87.
  15. Klein G, Giovanella BC, Lindahl T, et al (1974). Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with pooly differentiated virus carcinoma of nasopharynx. Proc Natl Acad Sci USA, 71, 4737-41.
  16. Kukita A, Kukita T, Ouchida M, et al (1999). Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional osteoclastogenesis. Blood, 94, 1987-97.
  17. Lin CC, Zhou JP, Liu YP, et al (2012). The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway. PLos One, 7, e51916.
  18. Liu F, Jiao W, Mo XL, et al (2013). The molecular pathological study of human nasopharyngeal carcinoma epithelial cell line CNE3. Oncol Lett, 6, 980-4.
  19. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.
  20. Maeda T, Hobbs RM, Merghoub T, et al (2005). Role of the proto-oncogene pokemon in cellular transformation and ARF repression. Nature, 433, 278-85.
  21. Pessler F, Pendergrast PS, Hernandez N (1997). Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol, 17, 3786-98.
  22. Robert E. Farrell (2008). RNA methodologies: a laboratory guide for isolation and characterization. 3rd ed. Chemical Industry Press, Beijing pp 109-11.
  23. Tao Q, Chan AT (2007). Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic development. Expert Rev Mol Med, 9, 1-24.
  24. Tsao SW, Wang X, Liu Y, et al (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta, 1590, 150-8.
  25. Wei K, Xu Y, Liu J, Zhang W, Liang Z (2010). No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007. Asian Pac J Cancer Prev, 11, 1595-9.
  26. Wei KR, Yu YL, Yang YY, et al (2010). Epidemiological Trends of Nasopharyngeal Carcinoma in China. Asian Pac J Cancer Prev, 11, 29-32.
  27. Wei MY, He RK, Liang XJ, Chen Z (1996). The relationship between the histological type of nasopharyngeal carcinoma and the expression of Epstein-Barr virus by in situ hybridization. J Guangxi Med Univ, 13, 10-3.
  28. Yang X, Zu X, Tang J, et al (2012). Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation. Mol Med Rep, 5, 1475-80.
  29. Yip YL, Tsang CM, Deng W, et al (2010). Expression of Esptein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells. J Med Virol, 82, 1711-23.
  30. Yoshizaki T, Kondo S, Wakisaka N, et al (2013). Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett, 337, 1-7.
  31. Zhang YQ, Xiao CX, Lin BY, et al (2013). Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells. PLoS One, 8, e68981.
  32. Zhu X, Dai Y, Chen Z, et al (2013). Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity. Oncol Res, 20, 377-81.

Cited by

  1. Glycididazole Sodium Combined with Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma vol.15, pp.6, 2014,
  2. Differences in Zbtb7a expression cause heterogeneous changes in human nasopharyngeal carcinoma CNE3 sublines vol.14, pp.3, 2017,
  3. The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder vol.14, pp.4, 2017,